Risk scores are statistical indicators based on prescribing patterns compared to specialty peers. They are NOT allegations of fraud, misconduct, or improper care. Many legitimate medical reasons can explain outlier prescribing.
Read our methodology →Risk Flags
Risk indicators are statistical patterns, not allegations. Learn more
172,165
Total Claims
$45.1M
Drug Cost
143,333
Beneficiaries
$314
Cost/Patient
Risk Score Breakdown 9/100
Score components are additive. Read full methodology
Peer Comparison vs. 18,720 Cardiology providers
-79%
Cost per patient vs peers
$314 vs $1,524 avg
+625%
Brand preference vs peers
98.9% vs 13.7% avg
⚠️ This provider has metrics more than 3 standard deviations above their specialty average in one or more categories.
Brand vs Generic
Brand: 170,342 claims · $45.0M
Generic: 1,823 claims · $67K
Top Prescribed Drugs
| Drug (Generic) | Claims | Cost |
|---|---|---|
| Rsvpref3 Antigen/As01e/Pf | 94,603 | $29.3M |
| Varicella-Zoster Ge/As01b/Pf | 56,868 | $12.1M |
| Rsv Vacc, Pref A And Pref B/Pf | 5,815 | $1.8M |
| Diphth,pertuss(Acell),tet Vac | 11,288 | $766K |
| Empagliflozin | 211 | $282K |
| Apixaban | 149 | $150K |
| Semaglutide | 130 | $147K |
| Rivaroxaban | 92 | $94K |
| Hepatitis A And B Vaccine/Pf | 357 | $51K |
| Dapagliflozin Propanediol | 35 | $50K |
| Alirocumab | 61 | $48K |
| Sacubitril/Valsartan | 33 | $40K |
| Evolocumab | 53 | $39K |
| Dabigatran Etexilate Mesylate | 14 | $13K |
| Hpv Vaccine 9-Valent/Pf | 41 | $13K |
Prescribing Profile
Patient Profile
74
Avg Age
56%
Female
0.97
Avg Risk Score
Explore More
Data from CMS Medicare Part D Prescriber Public Use File, 2023. Risk scores are statistical indicators, not allegations of wrongdoing.Methodology · About · Dispute this data